EVM
HURA

Eaton Vance Management’s TuHURA Biosciences HURA Stock Holding History

Eaton Vance Management’s Portfolio HURA Stock Details HURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6
Closed -$4K – 1825
2022
Q1 		$4K Hold
6
– – ﹤0.01% 1810
2021
Q4 		$5K Hold
6
– – ﹤0.01% 2656
2021
Q3 		$0 Buy
+6
New +$15.8K ﹤0.01% 2758

Other funds holding HURA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
S
swisspartners Vaduz, Liechtenstein $78.4M AUM 9.82% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Eaton Vance Management's HURA Position: Q2 2022 in Review

Eaton Vance Management sold out of TuHURA Biosciences (HURA) in Q2 2022, closing a stake of 6 shares — an estimated $4K sold.

Eaton Vance Management first reported a position in HURA in Q3 2021 and held it in 3 quarters. The position peaked at $5K in Q4 2021. 20 funds tracked by Wall St. Rank hold HURA as of Q2 2022.

  • Eaton Vance Management reported no remaining TuHURA Biosciences position as of Q2 2022 after selling out during the quarter.
  • Eaton Vance Management sold 6 TuHURA Biosciences shares in Q2 2022, an estimated $4K.
  • Eaton Vance Management first reported a position in TuHURA Biosciences in Q3 2021 and held it in 3 quarters.
  • Eaton Vance Management's TuHURA Biosciences position peaked at $5K in Q4 2021.
  • 20 funds tracked by Wall St. Rank held TuHURA Biosciences as of Q2 2022.

Based on Eaton Vance Management's 13F filing for Q2 2022, filed 15 Aug 2022.